Deep Transcranial Magnetic Stimulation (TMS)- Treatment for Post Traumatic Stress Disorder

Evaluation of the novel deep TMS H-Coil designs as a treatment measure in post traumatic stress disorder (PTSD).

Comparing real to sham treatment.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Post Traumatic Stress Disorder Mental Disorders Stress Disorders, Post-Traumatic Stress Disorders, Traumatic Trauma and Stressor Related Disorders

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 1 / Phase 2

Primary location

Psychiatric department, Hadassah-Hebrew universityMedical Organization

Jerusalem, Israel

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

PTSD diagnosis per DSM IV

Exclusion criteria

Schizophrenia
Bipolar I
severe Axis II diagnosis
risk factors to convulsions
drug / alcohol abuse

Treatment and study plan

Deep repetitive Transcranial Magnetic Stimulation (rTMS) real or sham

Device

Other names: Brainsway H-Coil

Primary outcomes

CAPS SCORE [TOTAL, INTRUSION]

Time frame: 4 weeks

Sponsors and collaborators

Lead sponsor

Hadassah Medical Organization

Other

Registry information

Official study title

Evaluation of the H-Coil Transcranial Magnetic Stimulation (TMS) Device- Treatment for Post Traumatic Stress Disorder

Important dates

Study start: 2008
Primary completion: 2011
Study completion: 2011
First posted: Aug 17, 2007
Registry last updated: Apr 21, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed